Clinical trial
Arterial Disease Multifactorial Intervention Trial (ADMIT)
NCT00000539 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00000539 |
|---|---|
| Title | Arterial Disease Multifactorial Intervention Trial (ADMIT) |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Arterial Occlusive Diseases, Cardiovascular Diseases, Heart Diseases, Vascular Diseases, Diabetes Mellitus |
| Intervention type | Behavioral, Drug |
| Interventions | niacin, pravastatin, beta-carotene, vitamin E, dietary supplements, vitamin C, warfarin |
| Start date | Sep 1, 1992 |
| Completion | Mar 1, 1999 |
| First posted | Oct 28, 1999 |
| Last update posted | Jul 12, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: